Market Value2,724,553,242
Total Holdings77
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PGNY / Progyny, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
IMVT / Immunovant, Inc.
BHVN / Biohaven Ltd.
ETNB / 89bio, Inc.
KYMR / Kymera Therapeutics, Inc.
LIVN / LivaNova PLC
CABA / Cabaletta Bio, Inc.
ANNX / Annexon, Inc.
ISRG / Intuitive Surgical, Inc.
CYTK / Cytokinetics, Incorporated
DCPH / Deciphera Pharmaceuticals, Inc.
ICLR / ICON Public Limited Company
ARDX / Ardelyx, Inc.
CTLT / Catalent, Inc.
PLRX / Pliant Therapeutics, Inc.
PRME / Prime Medicine, Inc.
HOOK / HOOKIPA Pharma Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
BOLD / Boundless Bio, Inc.
MCK / McKesson Corporation
HCA / HCA Healthcare, Inc.
ACIU / AC Immune SA
PEN / Penumbra, Inc.
CLDX / Celldex Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
RYZB / RayzeBio, Inc.
IMGN / ImmunoGen, Inc.
SPY / SPDR S&P 500 ETF
SLGC / Standard BioTools Inc.
NVTA / Invitae Corporation
BCEL / Atreca, Inc.
SRRK / Scholar Rock Holding Corporation
NRIX / Nurix Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
ABSI / Absci Corporation
IDYA / IDEAYA Biosciences, Inc.
VTYX / Ventyx Biosciences, Inc.
COGT / Cogent Biosciences, Inc.
LVTX / LAVA Therapeutics N.V.
XERS / Xeris Biopharma Holdings, Inc.
VERV / Verve Therapeutics, Inc.
ADCT / ADC Therapeutics SA
BEAM / Beam Therapeutics Inc.
FOLD / Amicus Therapeutics, Inc.
TRDA / Entrada Therapeutics, Inc.
EVH / Evolent Health, Inc.
CRL / Charles River Laboratories International, Inc.
RGNX / REGENXBIO Inc.
FATE / Fate Therapeutics, Inc.
IVVD / Invivyd, Inc.
ELAN / Elanco Animal Health Incorporated
ABT / Abbott Laboratories
DGX / Quest Diagnostics Incorporated
ELV / Elevance Health, Inc.
LAB / Standard BioTools Inc.
ALGN / Align Technology, Inc.
CI / The Cigna Group
RAPT / RAPT Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
ALVR / AlloVir, Inc.
MDVLQ / MedAvail Holdings, Inc.
REPL / Replimune Group, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
STXS / Stereotaxis, Inc.
SYK / Stryker Corporation
ATRA / Atara Biotherapeutics, Inc.
TKNO / Alpha Teknova, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
KROS / Keros Therapeutics, Inc.
IMNM / Immunome, Inc.
ESTA / Establishment Labs Holdings Inc.
BSX / Boston Scientific Corporation
STOK / Stoke Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
AUGX / Augmedix, Inc.
ALLK / Allakos Inc.
STTK / Shattuck Labs, Inc.
RPTX / Repare Therapeutics Inc.
NGNE / Neurogene Inc.
ALXO / ALX Oncology Holdings Inc.
GRTSQ / Gritstone bio, Inc.